NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · IEX Real-Time Price · USD
0.106
-0.006 (-5.13%)
Mar 28, 2024, 1:56 PM EDT - Market open

NovaBay Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2004
Net Income
-16.7-16.27-6.56-11.04-10.49-6.55-7.4-13.15-18.97-15.19
Upgrade
Depreciation & Amortization
0.20.480.120.050.070.270.10.110.160.23
Upgrade
Share-Based Compensation
0.290.220.930.530.710.672.511.621.381.04
Upgrade
Other Operating Activities
5.023.25-4.425.730.960.04-1.47-0.24-1.13-1.14
Upgrade
Operating Cash Flow
-4.13-6.65-9.19-4.72-7.93-5.57-6.27-11.66-18.56-15.06
Upgrade
Capital Expenditures
-0.02-0.11-0.05-0.03-0.02-0.04-0.24-0.16-0.090.06
Upgrade
Acquisitions
00-11.990000000
Upgrade
Change in Investments
0000000002.54
Upgrade
Investing Cash Flow
-0.02-0.11-12.05-0.03-0.02-0.04-0.24-0.16-0.092.6
Upgrade
Share Issuance / Repurchase
0.571.71.7812.336.965.60.2521.0812.770.26
Upgrade
Debt Issued / Paid
1.35-0.110.11-2.562.1500-1.662.837.13
Upgrade
Other Financing Activities
-3.0414.91-2.6--0.05---
Upgrade
Financing Cash Flow
1.914.6316.799.7611.75.60.219.4215.67.39
Upgrade
Net Cash Flow
-2.24-2.13-4.455.023.75-0.02-6.317.6-3.04-5.07
Upgrade
Free Cash Flow
-4.15-6.77-9.24-4.75-7.95-5.61-6.51-11.82-18.65-15
Upgrade
Free Cash Flow Margin
-28.18%-46.97%-90.59%-47.79%-120.44%-44.87%-35.73%-99.36%-425.59%-1422.68%
Upgrade
Free Cash Flow Per Share
-0.98-4.20-7.41-4.74-12.85-11.61-14.88-43.98-234.40-264.40
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).